Nonspecific extracellular proteins at tissue surfaces

Nonspecific extracellular proteins at tissue surfaces is a pharmacological classification used to describe the site of action for agents that do not bind to a specific molecular receptor, such as gadolinium-based contrast agents (GBCAs) [DrugBank, DB00601]. These proteins comprise the extracellular matrix (ECM) and interstitial fluid components, including collagen and proteoglycans, which maintain tissue architecture [NIH, StatPearls]. In diagnostic medicine, GBCAs like gadopentetate dimeglumine distribute into the extracellular space and interact with the local environment to enhance magnetic resonance imaging (MRI) signals [FDA, Magnevist Label]. This interaction is non-specific and depends on vascular permeability and the volume of the interstitial compartment rather than high-affinity binding [PubMed, PMID: 17545335]. While these proteins are not therapeutic targets that modulate disease pathways, they are critical for the pharmacokinetics of imaging agents and can be affected by conditions like fibrosis or inflammation [PubMed, PMID: 21243484]. Safety concerns associated with this target include Nephrogenic Systemic Fibrosis (NSF), a condition where gadolinium retention in the extracellular matrix leads to severe tissue thickening [FDA, Drug Safety Communication]. Furthermore, the accumulation of these agents in tissues like the brain has led to increased regulatory scrutiny regarding their long-term safety [EMA, Gadolinium-containing contrast agents].

Other names

Extracellular matrix proteinsInterstitial proteinsTissue surface proteinsExtracellular fluid proteins

These agents distribute into the extracellular fluid and interact with the local environment to alter the relaxation times of nearby water protons, thereby enhancing contrast in magnetic resonance imaging (MRI) [FDA, Magnevist Label; PubMed, PMID: 17545335].